Correlation Between Cabio Biotech and Oculis Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cabio Biotech and Oculis Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cabio Biotech and Oculis Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cabio Biotech Wuhan and Oculis Holding AG, you can compare the effects of market volatilities on Cabio Biotech and Oculis Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cabio Biotech with a short position of Oculis Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cabio Biotech and Oculis Holding.

Diversification Opportunities for Cabio Biotech and Oculis Holding

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cabio and Oculis is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Cabio Biotech Wuhan and Oculis Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oculis Holding AG and Cabio Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cabio Biotech Wuhan are associated (or correlated) with Oculis Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oculis Holding AG has no effect on the direction of Cabio Biotech i.e., Cabio Biotech and Oculis Holding go up and down completely randomly.

Pair Corralation between Cabio Biotech and Oculis Holding

Assuming the 90 days trading horizon Cabio Biotech Wuhan is expected to under-perform the Oculis Holding. In addition to that, Cabio Biotech is 1.2 times more volatile than Oculis Holding AG. It trades about -0.09 of its total potential returns per unit of risk. Oculis Holding AG is currently generating about 0.07 per unit of volatility. If you would invest  1,933  in Oculis Holding AG on September 6, 2025 and sell it today you would earn a total of  37.00  from holding Oculis Holding AG or generate 1.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.45%
ValuesDaily Returns

Cabio Biotech Wuhan  vs.  Oculis Holding AG

 Performance 
       Timeline  
Cabio Biotech Wuhan 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Cabio Biotech Wuhan has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2026. The current disturbance may also be a sign of long term up-swing for the company investors.
Oculis Holding AG 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Oculis Holding AG are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile fundamental indicators, Oculis Holding unveiled solid returns over the last few months and may actually be approaching a breakup point.

Cabio Biotech and Oculis Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cabio Biotech and Oculis Holding

The main advantage of trading using opposite Cabio Biotech and Oculis Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cabio Biotech position performs unexpectedly, Oculis Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oculis Holding will offset losses from the drop in Oculis Holding's long position.
Cabio Biotech vs. Yunnan Jianzhijia Health Chain
Cabio Biotech vs. By health
Cabio Biotech vs. Meinian Onehealth Healthcare
Cabio Biotech vs. Xinjiang Beixin RoadBridge
The idea behind Cabio Biotech Wuhan and Oculis Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Oculis Holding vs. GOME Retail Holdings
Oculis Holding vs. National Retail Properties
Oculis Holding vs. Bragg Gaming Group
Oculis Holding vs. Hochschild Mining PLC
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals


 
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY